Early Failure is Still a Poor Prognostic Factor in Patients with Relapsed or Refractory Large B-cell Lymphoma in the Era of CAR T-cell Therapy

Yu Yagi,Yusuke Kanemasa,Yuki Sasaki,Sotaro Goto, Yasuhiko Yamamura, Yusuke Masuda, Kumiko Fujita,Kento Ishimine,Yudai Hayashi,Mano Mino,An Ohigashi,Yuka Morita,Taichi Tamura,Shohei Nakamura,Toshihiro Okuya, Shinichiro Matsuda,Takuya Shimizuguchi,Naoki Shingai,Takashi Toya,Hiroaki Shimizu,Yuho Najima,Takeshi Kobayashi,Kyoko Haraguchi,Noriko Doki,Yoshiki Okuyama,Tatsu Shimoyama

JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY（2024）

Cited 0|Views4

Key words

relapsed or refractory diffuse large B-cell lymphoma,autologous stem cell transplantation,chimeric antigen receptor T-cell therapy,primary refractory,early relapse

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined